Vaccine used in Azerbaijan is effective against British strain - OFFICIAL
Health
- 18 March, 2021
- 09:02
The CoronoVAC vaccine produced by the Chinese company SinoVac, which is used against coronavirus infection in Azerbaijan, is also effective against new strains, the National Center for Hematology and Transfusion told Report.
501Y.V1 and B.1.1.7 (British version) were found in three samples analyzed by the Sars Cov-2 genome at the Center's Genetic Diagnostic Center.
Azerbaijan started the vaccination process on January 18. Vaccination is performed voluntarily and at state expense. To date, 468,826 people in the country have been vaccinated.
Latest News
17:51
Foreign investments in Azerbaijan's economy increase 28.7%
Finance17:38
Azerbaijan, Apple mull projects to create regional digital hub
ICT17:20
Azerbaijan, Nvidia considering joint initiatives to implement technologies in strategic areas
ICT17:00
Azerbaijan, OpenAI mull creation of infrastructure for sovereign artificial intelligence
ICT16:38
Jury orders Johnson & Johnson to pay $40M to two women in latest talc trial
Interesting16:13
Photo
SOCAR mulls co-op opportunities with Kyrgyzstan
Energy15:56
Azerbaijan mulls co-op with Meta in digital governance, innovative solutions
ICT15:32
Lachin tanker transported over 464,000 tons of oil, petroleum products since its commissioning
Infrastructure15:16